External beam radiation enhances antibody mediated radiocytotoxicity in human glioma cells in vitro

Anticancer Research

Volumn 17, Issue 3 B, 1997, Pages 1797-1802

  Bender, Hans ^a   Emrich, Jaqueline G ^b   Eshelman, Jeffrey ^b   Chu, Mary A ^b   Steplewski, Zenon ^c   Biersack, Hans J ^a   Brady, Luther W ^b  

^a UNIVERSITY OF BONN   (Germany)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

External beam radiation; Glioma cells; Monoclonal antibodies; Radiotoxicity

Indexed keywords

ANTIBODY; DOUBLE STRANDED DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; IODINE 125; MONOCLONAL ANTIBODY;

ARTICLE; CELL DAMAGE; CELL LINE; CELL SURVIVAL; CELL VOLUME; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOSE TIME EFFECT RELATION; GLIOMA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION; RADIATION INJURY; RECEPTOR BINDING; VASCULAR ENDOTHELIUM; X RAY;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CELL DIVISION; CELL SURVIVAL; GLIOMA; HUMANS; IMMUNOGLOBULIN G; IODINE RADIOISOTOPES; KINETICS; MICE; RADIOIMMUNOTHERAPY; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0030912770     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. DeLand FH: A perspective of monoclonal antibodies: past, present, and future. Semin Nucl Med 19: 158-165, 1989.
2. 125I labeled monoclonal antibody against epidermal growth factor receptor. Antibody, Immunoconjugates and Radiopharmaceuticals 3: 169-179, 1990.
3. Brady LW, Miyamoto C, Woo DV, Rackover M, Emrich J, Bender H, Dadparvar S, Steplewski Z, Koprowski H, Black P, Lazzaro B, Nair S, McCormack T, Nievis J, Morrabito M, Eshelman J: Malignant astrocytomas treated with Iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial. Int J Radiation Oncology Biol Phys 22: 225-230, 1992.
4. Libermann T, Nusbaum H, Razon N, Kris R, Lax I, Soreq H, Whittle M, Waterfield M, Ullrich A, Schlessinger J: Amplification and overexpression of the EGF receptor gene in primary human glioblastoma. J Cell Sci Suppl 3: 161-172, 1985.
5. Takahashi H, Herlyn D, Atkinson B, Powe J, Rodeck U, Alavi A, Bruce DA and Koprowski H: Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor. Cancer Res 47: 3847-3850, 1987.
6. Rakowicz-Szulczynska EM, Rodeck U, Herlyn M and Koprowski H: Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors. Proc Natl Acad Sci USA 83: 3728-3732, 1986.
7. Rakowicz-Szulczynska EM, Otwiaska D, Rodeck U and Koprowski H: Epidermal growth factor (EGF) and monoclonal antibody to cell surface EGF receptor bind to the same chromatin receptor. Arch Biochem Biophys 258: 456-464, 1989.
8. Bender H, Takahashi H, Adachi K, Belser P, Liang S, Prewett M, Schrappe M, Sutter A, Rodeck U and Herlyn D: Immunotherapy of human glioma xenografts with unlabeled. 1311-, or 1251-labeled monoclonal antibody 425 to epidermal growth factor receptor. Cancer Res 52: 121-126, 1992.
9. Sastry KSR: Biological effects of the Auger emitter iodine-125: A review Report No 1 of AAPM Nuclear Medicine Task Group No 6. Medical Phys 19: 1361-1370, 1992.
10. Basu A, Murthy U, Rodeck U, Herlyn M, Mattes L and Das M: Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. Cancer Res 47: 2531-2536, 1987.
11. Murthy U, Basu A, Rodeck U, Herlyn M, Ross AH and Das M: Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Arch Biochem Biophys 252: 549-560, 1987.
12. Rodeck U, Herlyn M, Molthoff C, Atkinson B, Varello M, Steplewski Z and Koprowski H: Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. Cancer Res 47: 3692-3696, 1987.
13. Fraker PJ and Speck JC: Protein and cell membrane iodination with sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenylglyoluril. Biochem Biophys Res Commun 80: 849-857, 1978.
14. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr: Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 72: 77-89, 1984.
15. Wargalla UC and Reisfeld RA: Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells. Proc Natl Acad Sci USA 86: 5146-5150, 1989.
16. Wiley HS and Cunningham DD: The endocytotic rate constant. J Biol Chem 25: 4222-4229, 1982.
17. Fleury C, Cotte J, Quero AM: Evaluation of the cytotoxicity of an antiseptic by a photometric micromethod. Pathol Biol (Paris) 32: 638-630, 1984.
18. Kalofonos H, Rowlinson and Epenetos AA: Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation. Cancer Res 50: 159-163, 1990.
19. Leichner PK, Yang NC, Frenkel TL, Loudenslager DM, Hawkins WG, Klein JL, Order SE: Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma. Int J Radiat Oncol Biol Phys 14: 1033-1042, 1988.
20. Quin DX, Zheng R, Tang J, Li LX, Hu YH: Influence of radiation On the blood brain barrier and optimum time of chemotherapy. Int J Radiat Oncol Biol Phys 19: 1507-1510, 1990.
21. Stickney DR, Gridley DS, Kirk GA and Slater JM: Enhancement of monoclonal antibody binding to melanoma with single dose radiation or hyperthermia. NCI Monogr 3: 47-52, 1987.
22. Wong JY, Williams LE, Hill LR, Paxton RJ, Beatty BG, Shively JE, Beatty JD: The effect of tumor mass, tumor age, and external beam radiation on tumor-specific antibody uptake. Int J Radiat Oncol Biol Phys 715-720, 1989.
23. Adachi K, Belser P, Bender H, Li D, Rodeck U, Beneviste T, Woo DV, Herlyn D: Enhancement of epidermal growth factor receptor (EGF-R) expression on glioma cells by recombinant tumor necrosis factor (rTNF)-a. Cane Immunol Immunother 34: 370-376, 1992.
24. Salazar OM, Rubin P, Feldstein ML, Pizutielio R: High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiation Oncology Biol Phys 5: 1733-1740, 1979.
25. Bloom HJG: Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980. Int J Radiation Oncology Biol Phys 8: 1083-1113, 1982.
26. Denekamp J, Fowler JF: Cell proliferation kinetics and radiation therapy. In: Beecker, FF (ed) Cancer: a comprehensive treatise. Plenum, New York, 101-128, 1977.
27. Fitzgerald TJ, Henault S, Sakakeeny M, Santucci MA, Pierce JH, Anklesaria P, Kase K, Das I, Greenberger JS: Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoetic and fibroblast cell lines selectively at clinical low dose rate. Radiation Res 122: 44-52, 1990.
28. Clayson DB, Metha R, Iverson F: International Commission for protection against environmental mutagens and carcinogens Oxidative DNA damage - the effects of certain genotoxic and operationally non-genotoxic carcinogens. Mutat Res 317: 25-42, 1994.
29. Harris AL: DNA repair: relationship to drug and radiation resistance, metastasis and growth factors. Int J Rad Biol Phys 48: 675-690, 1985.
30. Peacocke M, Yaar M, Mansur CP, Chao MV, Gilchrest BA: Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci USA 85: 5282-5286, 1988.
31. Janssen YM, Van-Houten B, Borm PJ, Mossman BT: Cell and tissue response to oxidative damage. Lab Invest 69: 261-274, 1993.
32. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW: Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest 87: 1794-1797, 1991.
33. Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, Eldor A: Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res 49: 5066-5072, 1989.
34. Yang XY, Ronai ZA, Santella RM, Weinstein IB: Effects of 8-methoxypsoralen and ultraviolet light A on EGF receptor (HER-1) expression. Biochem Biophys Res Commun 157: 590-596, 1988.
35. Ley KD, Ellem KA: UVC modulation of epidermal growth factor receptor number in HeLa S3 cells. Carcinogenesis 13: 183-187, 1992.